Goldstraw P, Mannam G C, Kaplan D K, Michail P
Royal Brompton and National Heart and Lung Hospital, London, United Kingdom.
J Thorac Cardiovasc Surg. 1994 Jan;107(1):19-27; discussion 27-8.
Between 1979 and 1989, 876 patients with non-small-cell lung carcinoma were referred to our unit for surgical treatment. One hundred forty-six patients were judged not suitable for surgical treatment on clinical, radiologic, or bronchoscopic findings. Cervical mediastinoscopy or anterior mediastinotomy (or both) showed that 151 patients had mediastinal involvement by invasion or metastases into the ipsilateral (N2 disease) or contralateral (N3 disease) superior mediastinal lymph nodes and were therefore deemed inoperable. Except for one patient who had involvement of a single nodal station at mediastinoscopy, all other patients (n = 578) undergoing thoracotomy were thought, on the basis of computed tomographic scan or mediastinal exploration (or both) not to have N2 disease. Despite our efforts to avoid surgery on patients with N2 disease, at thoracotomy routine mediastinal node dissection disclosed that 149 patients had unsuspected N2 disease. Resection was possible in 130 (87.3%) by pneumonectomy (n = 72), bilobectomy (n = 7), lobectomy (n = 49), or lesser resection (n = 2). In three patients the resection was incomplete (2.3%), but in 127 a complete resection was performed (85%). Histologic examination in these 149 patients showed that 72 tumors were squamous cell carcinoma, 54 adenocarcinoma, 14 large-cell carcinoma, and 9 of mixed type. Eight patients died in the hospital after thoracotomy. Adjuvant therapy was not used after complete resection. Complete follow-up was obtained in 134 patients and the mean follow-up period was 27.25 months (1 to 116 months). The actuarial 5-year survival for those having complete resection was 20.1%. There was a statistically significant difference favoring long-term survival in those patients with squamous cell carcinoma (p < 0.01) and those in whom only one nodal station was involved (p < 0.05). Neither the extent of resection nor the involvement of any specific nodal station influenced long-term survival. Despite rigorous preoperative investigations, routine mediastinal node dissection demonstrated mediastinal node metastasis for the first time at thoracotomy in 26% of our patients. We believe resection is justified in these patients, who have already necessarily incurred the morbidity and mortality of thoracotomy, so long as complete resection is possible.
1979年至1989年间,876例非小细胞肺癌患者被转至我科接受手术治疗。根据临床、放射学或支气管镜检查结果,146例患者被判定不适合手术治疗。颈部纵隔镜检查或前纵隔切开术(或两者同时进行)显示,151例患者因同侧(N2期疾病)或对侧(N3期疾病)上纵隔淋巴结受侵或转移而有纵隔受累,因此被认为无法手术。除1例在纵隔镜检查时仅有单个淋巴结站受累的患者外,所有其他接受开胸手术的患者(n = 578)根据计算机断层扫描或纵隔探查(或两者同时进行)被认为没有N2期疾病。尽管我们努力避免对N2期疾病患者进行手术,但在开胸手术时常规纵隔淋巴结清扫发现149例患者存在未被怀疑的N2期疾病。其中130例(87.3%)可行切除术,包括全肺切除术(n = 72)、双叶切除术(n = 7)、肺叶切除术(n = 49)或较小范围的切除术(n = 2)。3例患者切除不完全(2.3%),但127例患者进行了完全切除(85%)。这149例患者的组织学检查显示,72例肿瘤为鳞状细胞癌,54例为腺癌,14例为大细胞癌,9例为混合型。8例患者在开胸手术后死于医院。完全切除后未使用辅助治疗。134例患者获得了完整的随访,平均随访期为27.25个月(1至116个月)。完全切除患者的5年精算生存率为20.1%。鳞状细胞癌患者(p < 0.01)和仅有单个淋巴结站受累的患者(p < 0.05)在长期生存方面有统计学上的显著差异。切除范围和任何特定淋巴结站的受累情况均未影响长期生存。尽管进行了严格的术前检查,但常规纵隔淋巴结清扫在开胸手术时首次发现26%的患者存在纵隔淋巴结转移。我们认为,只要有可能进行完全切除,对于这些已经必然承受了开胸手术的发病率和死亡率的患者,进行切除是合理的。